CRSP — Crispr Therapeutics AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Crispr Therapeutics AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	1,690	2,379	1,815	1,694	1,904
Net Total Accounts Receivable
Net Total Receivables	0.144	0.305	0	200	25
Prepaid Expenses
Total Current Assets	1,717	2,418	1,853	1,908	1,937
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	93	312	321	306	278
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,828	2,752	2,243	2,230	2,242
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	94.3	120	121	109	87.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	164	352	368	347	310
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,664	2,399	1,875	1,883	1,932
Total Liabilities & Shareholders' Equity	1,828	2,752	2,243	2,230	2,242
Total Common Shares Outstanding